Trial · NCT01704261
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Hemoglobin A1c (A1C) at Week 24 | Omarigliptin | -0.67 | 95% Confidence Interval -0.84 to -0.50 | %A1C | |
| Change From Baseline in Hemoglobin A1c (A1C) at Week 24 | Placebo | -0.06 | 95% Confidence Interval -0.23 to 0.12 | %A1C | |
| Percentage of Participants Who Experienced at Least One Adverse Event (AE) | Omarigliptin | 57.5 | Percentage of participants | ||
| Percentage of Participants Who Experienced at Least One Adverse Event (AE) | Placebo | 47.7 | Percentage of participants | ||
| Percentage of Participants Who Discontinued From the Study Due to an AE | Omarigliptin | 2.6 | Percentage of participants | ||
| Percentage of Participants Who Discontinued From the Study Due to an AE | Placebo | 2.6 | Percentage of participants | ||
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 | Omarigliptin | -19.6 | 95% Confidence Interval -26.7 to -12.5 | mg/dL | |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 | Placebo | -3.0 | 95% Confidence Interval -10.2 to 4.1 | mg/dL | |
| Percentage of Participants Attaining A1C Glycemic Goals of <7% and <6.5% at Week 24 | Omarigliptin | <7.0% | 23.8 | 95% Confidence Interval 17.5 to 31.5 | Percentage of participants |
| Percentage of Participants Attaining A1C Glycemic Goals of <7% and <6.5% at Week 24 | Placebo | <7.0% | 4.4 | 95% Confidence Interval 2.1 to 9.3 | Percentage of participants |
| Percentage of Participants Attaining A1C Glycemic Goals of <7% and <6.5% at Week 24 | Omarigliptin | <6.5% | 10.1 | 95% Confidence Interval 6.1 to 16.4 | Percentage of participants |
| Percentage of Participants Attaining A1C Glycemic Goals of <7% and <6.5% at Week 24 | Placebo | <6.5% | 2.1 | 95% Confidence Interval 0.7 to 6.0 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01704261/results